Meeting to examine FDA requirements for manufacturing PET radiopharmaceuticals

Reston, VASNM and the International Partnership for Critical Markers of Disease (CMOD) are co-hosting an in-depth meeting on Friday, May 1, 2009, examining FDA requirements for manufacturing positron emission tomography (PET) radiopharmaceuticals. The meeting, which takes place at the Natcher Audi...

Supply of Radiopharmaceuticals Hampered by Attacks

As a result of the September 11 terrorist acts in New York and Washington DC, air transportation in the United States was put on hold for several days, which severely affected the production and distribution of radiopharmaceuticals. Most radiopharmaceuticals are shipped via air due to their sp...

SNM's Clinical Trials Network expands European membership of PET biomarker manufacturers

... Reston, Va.SNM's Clinical Trials Network today announced that several leading commercial providers of PET radiopharmaceuticals in Europe have registered their manufacturing sites with the network. SNM's Clinical Trials Network is an initiative designed to address the need for ...

New chemistry techniques improve hybrid scanner performance

...pital, Osaka, Japan. "This ability opens up exciting new opportunities in research in terms of increased understanding of kinetics, biodistribution of radiopharmaceuticals and, eventually, disease characteristics and physiological processes. Next steps include imaging body tumors in rats or mice and developing PET/MRI sy...

Siemens Makes Innovation Accessible with Comprehensive Molecular Imaging Solutions

...itals, clinics, and research facilities. Siemens PETNET operations have strategically expanded to include international locations and to provide SPECT radiopharmaceuticals through an agreement with Covidien Medical Imaging, further developing its PET and SPECT coverage. As the global economic crisis con...

MDS Nordion Opens New Radiopharmaceutical Production Facility in Belgium

...d Therapy Management OTTAWA and FLEURUS, Belgium, May 28 /PRNewswire-FirstCall/ - MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals used in molecular medicine, today announced the opening of a facility in Fleurus, Belgium for the production of Glucotrace (Fluorodeoxyglucose), a rad...

DRAXIMAGE(R)'s generic Sestamibi Approved for launch in USA

... DRAXIMAGE, develops, manufactures and markets diagnostic and therapeutic radiopharmaceuticals for the global nuclear medicine marketplace. Products include a proprieta...l medical imaging procedures. DRAXIMAGE is also a leading supplier of I-131 radiopharmaceuticals in North America, used for the diagnosis and treatment of thyroid disorder ...

Cardinal Health Extends Radiopharmaceutical Manufacturing Network to Nebraska

...o support oncology, neurology and cardiac imaging procedures, including new radiopharmaceuticals for use in clinical trials. The imaging agents produced at the facility wil...ates, with nearly 160 nuclear pharmacy locations that compound and dispense radiopharmaceuticals that aid in the early detection and treatment of disease. The company also ...

FDA Clears Cellectar's IND Application for Lead Drug Candidate

... (131)I-CLR1404 to Enter Clinical Trials MADISON, Wis., March 3 /PRNewswire/ -- Cellectar, Inc., a privately held radiopharmaceuticals company that designs and develops products to detect, treat and monitor human cancers, today announced that the U.S. Food and Drug Administration (FDA...

ProteoTech Receives Funding From The Michael J. Fox Foundation for Parkinson's Disease Research to Develop Tools for Imaging Alpha-Synuclein Aggregation in Living Parkinson's Brain

...Fox Foundation for Parkinson's Disease Research. In collaboration with Avid radiopharmaceuticals Inc. (Philadelphia, PA), ProteoTech scientists will utilize ProteoTech's sm...fficer of ProteoTech, and Dr. Franz Hefti, Chief Scientific Officer of Avid radiopharmaceuticals Inc. (Logo: http://www.newscom.com/cgi-bin/prnh/20090226/SF76109LOG...

Radiopharmaceuticals in Medical Technology

Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy

...or Cells as Patient-Specific Anti-Tumor Vaccines in Patients with Metastatic Melanoma," was published in the June 2009 issue of Cancer Biotherapy and radiopharmaceuticals and was sponsored by Hoag Hospital Foundation. "There is continued interest in developing new therapies for melanoma patients with recurrent ...

Cardinal Health Expands PET Nuclear Pharmacy Services to Support Clinical Drug Trials

...based PET radiopharmaceutical manufacturing facilities. These facilities are registered with the Food and Drug Administration (FDA) to manufacture PET radiopharmaceuticals that are used by physicians to diagnose various medical conditions. The company will now offer its PET manufacturing and distribution services to su...

Cellectar Expands Clinical Management Team

..., Wis., Oct. 3 /PRNewswire/ -- Cellectar LLC, (Cellectar), a privately-held radiopharmaceuticals company that designs and develops products to detect, treat and monitor hum...e Phase I clinical trails in mid-2008. About Cellectar Cellectar LLC is a radiopharmaceuticals company that designs and develops products to detect, treat and monitor a w...

Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop

...rotein levels, and better preservation of bone mineral density. Multiple myeloma is also a highly radiosensitive skeletal malignancy, yet bone-seeking radiopharmaceuticals such as QUADRAMET have not yet found their place in either pain palliation or disease management. Accordingly, the primary objective of the Phase 1 do...

Radiopharmaceuticals in Medical Definition

Nuclear medicine

...nuclides , or pharmaceuticals that have been labeled with radionuclides ( radiopharmaceuticals ). In diagnosis, radioactive substances are administered to patients and ... Reference 1. Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. Administration of radioactive substa...

Radiopharmaceuticals in Biological News

Study shows cancer vaccines led to long-term survival for patients with metastatic melanoma

...or Cells as Patient-Specific Anti-Tumor Vaccines in Patients with Metastatic Melanoma," was published in the June 2009 issue of Cancer Biotherapy and radiopharmaceuticals and was sponsored by Hoag Hospital Foundation. "There is continued interest in developing new therapies for melanoma patients with recurrent or d...

SNM Symposium on Multimodality Cardiovascular Molecular Imaging

... SNM and the International Partnership for Critical Markers of Disease will host a satellite meeting devoted to FDA requirements for manufacturing PET radiopharmaceuticals the evening of Friday, May 1. This meeting will take place immediately following the conclusion of the Multimodality Cardiovascular Molecular Imaging ...

Emergency response and nanotechnology

...onal Institute for Occupational Safety and Health safety plan for working with nanoparticles (Wednesday, 4:15 p.m.) Potential use of nanoparticles as radiopharmaceuticals (Wednesday, 4:30 p.m.) Panel discussion on nanotechnology (Wednesday beginning at 4:45 p.m.) ...

Radiation, nanotechnology, health care and more

...onal Institute for Occupational Safety and Health safety plan for working with nanoparticles (Wednesday, 4:15 p.m.) Potential use of nanoparticles as radiopharmaceuticals (Wednesday, 4:30 p.m.) Panel discussion on nanotechnology begins at 4:45 p.m. on Wednesday. Other Meeting Highlights TREATING CANCER WITH M...

Patients to benefit from novel technology revolutionizing high-speed molecular imaging

...adiation dose, and personalized scanning takes into account unique patient physiology and anatomy, he added. "Simultaneous imaging of a combination of radiopharmaceuticals can be used to define a specific disease signature leading to noninvasive biopsy," he detailed. The D-SPECT camera will provide "a potential breakthro...

Use of PET can reduce, may eliminate more strenuous drug development trials with animals

...can be obtained noninvasively, repeatedly and quantitatively in the same animal, he said. With small animal imaging, one can very rapidly evaluate new radiopharmaceuticals using a limited number of animals and possibly eliminate the need for biopsies, extending an animal's life. PET provides a noninvasive view into a ...

Radiopharmaceuticals in Biological Technology

House and Senate Pass Medicare Legislation to Freeze 2008 Reimbursement for Therapeutic Radiopharmaceuticals at 2007 Levels

Bill assures patients continue to have access to ZEVALIN(R) and other novel radioimmunotherapies SEATTLE, Dec. 20 /PRNewswire-FirstCall/ -- New Medicare legislation passed by the House and Senate extends the 2007 reimbursement methodology for radiopharmaceuticals into 20...

Frost & Sullivan Recognizes Cisbio Bioassays for Technology Innovation

... Founded in 1986 in Louvain-la-Neuve, Belgium, IBA is primarily active in the medical industry. It develops and markets state-of-the-art equipment and radiopharmaceuticals for cancer diagnosis and treatment. In addition, it uses the scientific expertise thus gained to provide electron accelerators for industrial steriliz...

Tengion Announces Second Closing of Series C Financing

...n and Gilead Sciences. Dr. Kurtzman currently sits on the Board of Directors for Safeguard's partner companies Advanced BioHealing , Alverix , Avid radiopharmaceuticals and NuPathe . "Safeguard Scientifics looks to partner with life sciences companies that are poised to dramatically revolutionize and improv...

Charles C. Harwood, Jr., Joins Cellectar, Inc.'s Board of Directors

... MADISON, Wis., Sept. 18 /PRNewswire/ -- Cellectar, Inc., a privately-held radiopharmaceuticals company that designs and develops products to detect, treat and monitor human cancers, today announced the appointment of Charles C. Harwood, Jr., to ...

First semiconductor-based PET scanner demonstrates potential to aid in early diagnosis of disease

...painless medical tests that help physicians diagnose medical conditions or conduct research. PET scans involve the use of radioactive materials called radiopharmaceuticals or radiotracers, which eventually collect in the area being examined and give off energy in the form of gamma rays. This energy is detected by a PET s...

Siemens to Launch PETNET Services in India

...the United Kingdom that produce and distribute PET radiopharmaceuticals to hospitals, clinics, and research facilities for...ty in Chennai will produce and supply the required radiopharmaceuticals to hospitals that have positron emission tomograph... cyclotron will guarantee reliable delivery of PET radiopharmaceuticals and will vastly increase availability of FDG, whic...

Cellectar, Inc. Raises $13 Million in Private Offering

...g) status with the FDA in the coming weeks in order to enter Phase 1 clinical trials during the summer of 2008. About Cellectar Cellectar LLC is a radiopharmaceuticals company that designs and develops products to detect, treat and monitor a wide variety of human cancers. Cellectar's novel product candidates combine ...

NorthStar signs exclusive agreement with Illinois foundation

...ndling, and faster preparation times, which are crucial for new short-lived radiopharmaceuticals to be effective. Since each dose of the radioisotope is produced with nearl... processing methods and speed, will have a dramatic impact on production of radiopharmaceuticals used today and in the future," said George Messina, founder and managing di...

GE begins human trials for cancer detection agent

...d with small amounts of radiopharmaceuticals, which create images of tissue chemical changes that could be early warning signs of cancer. Uses for the radiopharmaceuticals include spotting changes in glucose metabolism, monitoring the effectiveness of drug therapy during cancer treatments, and tracking whether tumors are...